Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Accounts Payables (2016 - 2017)

Bone Biologics has reported Accounts Payables over the past 3 years, most recently at $216903.0 for Q4 2017.

  • Quarterly Accounts Payables fell 16.62% to $216903.0 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $216903.0 through Dec 2017, down 16.62% year-over-year, with the annual reading at $216903.0 for FY2017, 16.62% down from the prior year.
  • Accounts Payables was $216903.0 for Q4 2017 at Bone Biologics, down from $740064.0 in the prior quarter.
  • Over five years, Accounts Payables peaked at $740064.0 in Q3 2017 and troughed at $159096.0 in Q1 2017.
  • The 3-year median for Accounts Payables is $335622.0 (2016), against an average of $381328.8.
  • The largest YoY upside for Accounts Payables was 120.51% in 2017 against a maximum downside of 67.13% in 2017.
  • A 3-year view of Accounts Payables shows it stood at $322078.0 in 2015, then decreased by 19.23% to $260149.0 in 2016, then dropped by 16.62% to $216903.0 in 2017.
  • Per Business Quant, the three most recent readings for BBLG's Accounts Payables are $216903.0 (Q4 2017), $740064.0 (Q3 2017), and $432330.0 (Q2 2017).